A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults
- Submitting institution
-
University of Oxford
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 13243
- Type
- D - Journal article
- DOI
-
10.1016/j.vaccine.2019.10.102
- Title of journal
- Vaccine
- Article number
- -
- First page
- 779
- Volume
- 38
- Issue
- 2020
- ISSN
- 0264-410X
- Open access status
- Compliant
- Month of publication
- November
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
19
- Research group(s)
-
-
- Citation count
- 13
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to carrying out the study AND to analysis and interpretation of study data. The author helped draft the output.
- Non-English
- No
- English abstract
- -
